ZA9711051B - Benzodioxole benzofuran dihydrobenzofuran and benzodioxane melatonergic agents - Google Patents

Benzodioxole benzofuran dihydrobenzofuran and benzodioxane melatonergic agents

Info

Publication number: ZA9711051B
Authority: ZA; South Africa
Prior art keywords: benzodioxane; benzodioxole; dihydrobenzofuran; benzofuran; melatonergic agents
Prior art date: 1996-12-10

Application number

ZA9711051A

Other languages

English (en)

Inventor

John D Catt

Daniel J Keavy

Michael F Parker

Joseph P Yevich

Graham Johnson

Ronald J Mattson

Katherine S Takaki

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-10

Filing date

1997-12-09

Publication date

1999-06-09

1997-12-09 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

1999-06-09 Publication of ZA9711051B publication Critical patent/ZA9711051B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Anesthesiology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Furan Compounds (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Pyrane Compounds (AREA)
Polyesters Or Polycarbonates (AREA)
Adhesives Or Adhesive Processes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

ZA9711051A 1996-12-10 1997-12-09 Benzodioxole benzofuran dihydrobenzofuran and benzodioxane melatonergic agents ZA9711051B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US3268996P	1996-12-10	1996-12-10

Publications (1)

Publication Number	Publication Date
ZA9711051B true ZA9711051B (en)	1999-06-09

Family

ID=21866306

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9711051A ZA9711051B (en)	1996-12-10	1997-12-09	Benzodioxole benzofuran dihydrobenzofuran and benzodioxane melatonergic agents

Country Status (25)

Country	Link
US (3)	US5856529A (fr)
EP (1)	EP1027043B1 (fr)
JP (1)	JP4290765B2 (fr)
KR (1)	KR100499106B1 (fr)
CN (1)	CN1152679C (fr)
AR (1)	AR010346A1 (fr)
AT (1)	ATE281833T1 (fr)
AU (1)	AU719994B2 (fr)
BR (1)	BR9713690B1 (fr)
CA (1)	CA2274183C (fr)
CY (1)	CY2501B1 (fr)
CZ (1)	CZ297673B6 (fr)
DE (1)	DE69731562T2 (fr)
DK (1)	DK1027043T3 (fr)
ES (1)	ES2230626T3 (fr)
HU (1)	HU226524B1 (fr)
IL (1)	IL129999A (fr)
NO (1)	NO321450B1 (fr)
NZ (1)	NZ335910A (fr)
PL (1)	PL190499B1 (fr)
PT (1)	PT1027043E (fr)
RU (1)	RU2190609C2 (fr)
TW (1)	TW476758B (fr)
WO (1)	WO1998025606A1 (fr)
ZA (1)	ZA9711051B (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9614347D0 (en) *	1996-07-09	1996-09-04	Smithkline Beecham Spa	Novel compounds
US6160134A (en) *	1997-12-24	2000-12-12	Bristol-Myers Squibb Co.	Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
CA2334299A1 (fr) *	1998-06-05	1999-12-09	Pierre Dextraze	Melatonergiques a base de derives cis heterocycliques de cyclopropane
AU763963B2 (en) *	1999-06-30	2003-08-07	Bristol-Myers Squibb Company	Heterocyclic aminopyrrolidine derivatives as melatonergic agents
ATE327753T1 (de)	2001-05-15	2006-06-15	Hoffmann La Roche	Carbonsäure-substituierte oxazol-derivate zur verwendung als ppar-alpha und -gamma aktivatoren zur behandlung von diabetes
JP2005505586A (ja) *	2001-10-04	2005-02-24	ワイス	５−ヒドロキシトリプタミン−６リガンドとしてのクロマン誘導体
US6569894B1 (en)	2001-10-04	2003-05-27	Bristol-Myers Squibb Company	Arylalkylbenzofuran derivatives as melatonergic agents
US6737431B2 (en)	2002-03-12	2004-05-18	Bristol-Myers Squibb Company	Benzoxazole derivatives as novel melatonergic agents
RU2295520C2 (ru) *	2002-07-03	2007-03-20	Ф.Хоффманн-Ля Рош Аг	ПРОИЗВОДНЫЕ ОКСАЗОЛА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ СЕНСИБИЛИЗАТОРОВ ИНСУЛИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АКТИВИРУЮЩИМ ДЕЙСТВИЕМ В ОТНОШЕНИИ PRARα И/ИЛИ PRARγ
EP1537091B1 (fr) *	2002-08-30	2010-10-06	F. Hoffmann-La Roche AG	Nouveaux composes 2-arylthiazole utilises comme agonistes des recepteurs pparalpha et ppargamma
JP4286782B2 (ja) *	2002-09-12	2009-07-01	エフ．ホフマン−ラロシュアーゲー	糖尿病の治療に有用な、ｐｐａｒアゴニストとしてのｎ−置換−１ｈ−インドール−５−プロピオン酸化合物
RU2315767C2 (ru) *	2002-11-25	2008-01-27	Ф.Хоффманн-Ля Рош Аг	Индолилпроизводные, способ их получения, фармацевтическая композиция, способ лечения и/или профилактики заболеваний
US7015831B2 (en) *	2002-12-17	2006-03-21	Evolution Robotics, Inc.	Systems and methods for incrementally updating a pose of a mobile device calculated by visual simultaneous localization and mapping techniques
MY147767A (en) *	2004-06-16	2013-01-31	Janssen Pharmaceutica Nv	Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
RU2445973C2 (ru) *	2006-05-22	2012-03-27	Ванда Фармасьютиклз, Инк.	Способ лечения глубокой депрессии у человека
MX2008014841A (es) *	2006-05-22	2008-12-05	Vanda Pharmaceuticals Inc	Tratamiento de agonista de melatonina.
EP2141150B1 (fr) *	2007-04-26	2013-12-11	Takeda Pharmaceutical Company Limited	Composé bicyclique et son utilisation pharmaceutique
US7964430B2 (en) *	2007-05-23	2011-06-21	Applied Materials, Inc.	Silicon layer on a laser transparent conductive oxide layer suitable for use in solar cell applications
US11060144B2 (en) *	2007-09-13	2021-07-13	Vanda Pharmaceuticals Inc.	Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype
US20120136050A1 (en)	2009-07-16	2012-05-31	Vanda Pharmaceuticals Inc.	Use of a melatonin agonist for the treatment of sleep disorders including primary insomnia
EP2287159A1 (fr) *	2009-07-29	2011-02-23	V.Mane Fils	Nouveaux dioxanes bicycliques, leur préparation et leur utilisation en tant que composés organoleptiques
JP4944286B1 (ja) *	2010-09-22	2012-05-30	エーザイ・アール・アンド・ディー・マネジメント株式会社	シクロプロパン化合物
US9532952B2 (en)	2011-01-28	2017-01-03	Physician's Seal, LLC	Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (fr)	2011-01-28	2012-08-02	Zx Pharma, Llc	Composition de mélatonine à libération contrôlée et procédés associés
US11918557B2 (en)	2012-01-26	2024-03-05	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
EP4502609A3 (fr)	2012-01-26	2025-04-09	Vanda Pharmaceuticals Inc.	Détermination d'un rythme circadien
MX2014014010A (es) *	2012-05-18	2015-02-12	Vanda Pharmaceuticals Inc	Metabolitos de (1r-trans) -n - [[2- (2,3-dihidro-4-benzofuranilo) ciclopropilo] metilo] propanamida.
JPWO2014010603A1 (ja)	2012-07-10	2016-06-23	アステラス製薬株式会社	腹圧性尿失禁又は混合型尿失禁の治療又は予防用医薬組成物、及び該医薬組成物に含有される化合物のスクリーニング方法
AR091699A1 (es)	2012-07-10	2015-02-25	Astellas Pharma Inc	Derivado de indol carboxamida
CN110200958A (zh)	2012-12-18	2019-09-06	万达制药公司	昼夜节律紊乱的治疗
US9643947B2 (en)	2013-08-28	2017-05-09	Northwestern University	7-membered fused heterocycles and methods of their synthesis
US9573921B2 (en) *	2013-09-30	2017-02-21	Polfarmex S.A.	Substituted N, N-dimethylaminoalkyl ethers of isoflavanone oximes as H1-receptor antagonists
US11090285B2 (en)	2013-11-12	2021-08-17	Vanda Pharmaceuticals Inc	Treatment of circadian rhythm disorders
US10376487B2 (en)	2013-11-12	2019-08-13	Vanda Pharmaceuticals Inc.	Method of treatment
WO2015117048A1 (fr)	2014-01-31	2015-08-06	Vanda Pharmaceuticals Inc.	Traitement de troubles du rythme circadien
US12304896B2 (en)	2014-12-04	2025-05-20	Vanda Pharmaceuticals Inc.	Highly purified pharmaceutical grade tasimelteon
US10071977B2 (en)	2014-02-12	2018-09-11	Vanda Pharmaceuticals Inc.	Highly purifid pharmaceutical grade tasimelteon
HRP20230070T1 (hr)	2014-09-02	2023-03-17	Vanda Pharmaceuticals Inc.	Tasimelteon za liječenje smith-magenis sindroma
CN104327022B (zh) *	2014-10-17	2015-12-02	苏州明锐医药科技有限公司	他司美琼的制备方法
CN104402849B (zh) *	2014-11-11	2016-11-09	苏州莱克施德药业有限公司	他司美琼中间体的新制备工艺
CN106588841B (zh) *	2015-10-19	2019-01-25	富乐马鸿凯（大连）医药有限公司	合成2,3-二氢-1-苯并呋喃-4-甲醛的方法
KR20190008265A (ko)	2016-05-06	2019-01-23	피지션즈 씰, 엘엘씨	발레리안 조성물 및 관련 방법
CN105949153B (zh) *	2016-05-10	2018-03-02	浙江工业大学	一种他司美琼的合成方法
CN107365288A (zh) *	2016-05-12	2017-11-21	浙江京新药业股份有限公司	他司美琼的晶型
US9944616B2 (en)	2016-06-08	2018-04-17	Apotex Inc.	Processes for the preparation of Tasimelteon and intermediates thereof
CN106543119B (zh) *	2016-09-22	2019-07-26	浙江工业大学	一种光学纯他司美琼的制备方法
BR102016024814A2 (pt)	2016-10-24	2018-05-08	Aché Laboratórios Farmacêuticos S.A.	composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono
WO2018149940A1 (fr)	2017-02-17	2018-08-23	Quimica Sintetica, S. A.	Procédé de préparation de dihydrobenzofuranes enrichis de manière énantiomérique et composés intermédiaires obtenus durant le procédé
US20210059973A1 (en)	2017-08-02	2021-03-04	Vanda Pharmaceuticals Inc.	Treatment of Affective Disorders
WO2019173180A1 (fr) *	2018-03-04	2019-09-12	Vanda Pharmaceuticals Inc.	Traitement de troubles avec tasimelteon
CN113365618A (zh) *	2018-09-12	2021-09-07	万带兰制药公司	改善睡眠或睡醒后表现
MX2021012833A (es)	2019-05-15	2021-11-25	Eisai R&D Man Co Ltd	Metodo y compuesto utiles en la preparacion del antagonista del receptor de orexina-2 y lemborexant que tiene pocas impurezas.
WO2021003086A1 (fr)	2019-06-29	2021-01-07	Vanda Pharmaceuticals Inc.	Utilisation de tasimeltéon dans le traitement d'aberrations du sommeil
MX2022006577A (es) *	2019-12-13	2022-07-04	Vanda Pharmaceuticals Inc	Formulaciones liquidas de tasimelteon y metodos para su uso.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5071875A (en) *	1989-09-25	1991-12-10	Northwestern University	Substituted 2-amidotetralins as melatonin agonists and antagonists
FR2658818B1 (fr) *	1990-02-27	1993-12-31	Adir Cie	Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2667316B1 (fr) *	1990-10-02	1994-09-16	Roussel Uclaf	Nouveaux derives du benzofuranne, leur procede de preparation et leur application comme pesticides.
FR2674524B1 (fr) *	1991-03-25	1993-05-21	Adir	Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2680366B1 (fr) *	1991-08-13	1995-01-20	Adir	Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2680507B1 (fr) *	1991-08-23	1993-10-08	Adir Cie	Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2689124A1 (fr) *	1992-03-27	1993-10-01	Adir	Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5449683A (en) *	1992-10-01	1995-09-12	Massachussetts Institute Of Technology	Methods of inducing sleep using melatonin
FR2696453B1 (fr) *	1992-10-02	1994-12-23	Adir	Nouveaux arylalkyl(thio)amides, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent.
GB9326192D0 (en) *	1993-12-22	1994-02-23	Glaxo Group Ltd	Chemical compounds
GB9407919D0 (en) *	1994-04-21	1994-06-15	Glaxo Group Ltd	Chemical compounds
FR2725985B1 (fr) *	1994-10-21	1996-11-15	Adir	Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5633218A (en) *	1995-05-24	1997-05-27	E. I. Du Pont De Nemours And Company	Herbicidal benzodioxoles and benzodioxanes
US5596019A (en) *	1995-06-07	1997-01-21	Bristol-Myers Squibb Company	N-acyl-cycloalkylamine derivatives as melatonergics
CA2176854A1 (fr) *	1995-06-07	1996-12-08	Daniel J. Keavy	Derives de n-acyl-2-arylcyclopropylmethylamine, agents melatonergiques
PT901483E (pt) *	1996-05-14	2003-11-28	Glaxo Group Ltd	Benzofuranos e benzopiranos como agentes cronobiologicos

1997
- 1997-12-09 WO PCT/US1997/022627 patent/WO1998025606A1/fr not_active Ceased
- 1997-12-09 PL PL97333950A patent/PL190499B1/pl unknown
- 1997-12-09 DE DE69731562T patent/DE69731562T2/de not_active Expired - Lifetime
- 1997-12-09 CA CA002274183A patent/CA2274183C/fr not_active Expired - Lifetime
- 1997-12-09 US US08/987,478 patent/US5856529A/en not_active Expired - Lifetime
- 1997-12-09 ES ES97952354T patent/ES2230626T3/es not_active Expired - Lifetime
- 1997-12-09 NZ NZ335910A patent/NZ335910A/xx not_active IP Right Cessation
- 1997-12-09 IL IL12999997A patent/IL129999A/en not_active IP Right Cessation
- 1997-12-09 TW TW086118524A patent/TW476758B/zh active
- 1997-12-09 AU AU55985/98A patent/AU719994B2/en not_active Expired
- 1997-12-09 BR BRPI9713690-5A patent/BR9713690B1/pt not_active IP Right Cessation
- 1997-12-09 ZA ZA9711051A patent/ZA9711051B/xx unknown
- 1997-12-09 RU RU99115102/04A patent/RU2190609C2/ru active
- 1997-12-09 EP EP97952354A patent/EP1027043B1/fr not_active Expired - Lifetime
- 1997-12-09 CN CNB971804443A patent/CN1152679C/zh not_active Expired - Lifetime
- 1997-12-09 HU HU0000695A patent/HU226524B1/hu unknown
- 1997-12-09 AT AT97952354T patent/ATE281833T1/de active
- 1997-12-09 DK DK97952354T patent/DK1027043T3/da active
- 1997-12-09 PT PT97952354T patent/PT1027043E/pt unknown
- 1997-12-09 KR KR10-1999-7005148A patent/KR100499106B1/ko not_active Expired - Lifetime
- 1997-12-09 JP JP52692198A patent/JP4290765B2/ja not_active Expired - Lifetime
- 1997-12-09 CZ CZ0199199A patent/CZ297673B6/cs not_active IP Right Cessation
- 1997-12-10 AR ARP970105795A patent/AR010346A1/es active IP Right Grant
1998
- 1998-10-09 US US09/169,784 patent/US5981571A/en not_active Expired - Lifetime
1999
- 1999-06-09 NO NO19992804A patent/NO321450B1/no not_active IP Right Cessation
- 1999-07-13 US US09/352,560 patent/US6060506A/en not_active Expired - Lifetime
2005
- 2005-01-31 CY CY0500008A patent/CY2501B1/xx unknown

Also Published As

Publication number	Publication date
NO992804L (no)	1999-08-09
PT1027043E (pt)	2005-02-28
AR010346A1 (es)	2000-06-07
PL333950A1 (en)	2000-01-31
BR9713690A (pt)	2000-05-02
CA2274183C (fr)	2006-10-24
PL190499B1 (pl)	2005-12-30
NO992804D0 (no)	1999-06-09
BR9713690B1 (pt)	2009-08-11
WO1998025606A1 (fr)	1998-06-18
CZ199199A3 (cs)	1999-09-15
ES2230626T3 (es)	2005-05-01
JP4290765B2 (ja)	2009-07-08
HUP0000695A2 (hu)	2001-05-28
KR20000069396A (ko)	2000-11-25
HK1029947A1 (en)	2001-04-20
CY2501B1 (en)	2005-09-02
KR100499106B1 (ko)	2005-07-01
DE69731562T2 (de)	2005-11-24
HUP0000695A3 (en)	2002-09-30
IL129999A (en)	2004-06-20
CA2274183A1 (fr)	1998-06-18
IL129999A0 (en)	2000-02-29
US5856529A (en)	1999-01-05
AU719994B2 (en)	2000-05-18
US6060506A (en)	2000-05-09
US5981571A (en)	1999-11-09
TW476758B (en)	2002-02-21
EP1027043B1 (fr)	2004-11-10
DE69731562D1 (de)	2004-12-16
JP2001505916A (ja)	2001-05-08
NO321450B1 (no)	2006-05-15
CZ297673B6 (cs)	2007-02-28
CN1152679C (zh)	2004-06-09
EP1027043A4 (fr)	2002-02-20
RU2190609C2 (ru)	2002-10-10
AU5598598A (en)	1998-07-03
NZ335910A (en)	2000-11-24
EP1027043A1 (fr)	2000-08-16
HU226524B1 (en)	2009-03-30
DK1027043T3 (da)	2005-01-10
ATE281833T1 (de)	2004-11-15
CN1239886A (zh)	1999-12-29

Publication	Publication Date	Title
ZA9711051B (en)	1999-06-09	Benzodioxole benzofuran dihydrobenzofuran and benzodioxane melatonergic agents
AU2953197A (en)	1997-12-05	Benzofurans and benzopyrans as chronobiological agents
ID23872A (id)	2000-05-25	Komposisi farmasi padat yang mengandung turunan benzofuran
HUP9902901A3 (en)	2002-01-28	Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta[b]benzofurans
CZ20012041A3 (cs)	2001-10-17	Benzofuranové deriváty
PL332141A1 (en)	1999-08-30	Method of obtaining fluoxetin
SI0901483T1 (en)	2003-12-31	Benzofurans and benzopyrans as chronobiological agents
TW305463U (en)	1997-05-11	Improved structure of mouse pad
TW392874U (en)	2000-06-01	Improved structure of mouse pad
TW303779U (en)	1997-04-21	Modified structure of multi-functional pen blade
GB9802748D0 (en)	1998-04-08	Benzofurans and their therapeutic use
GB9812322D0 (en)	1998-08-05	Benzofurans and their therapeutic use
TW303974U (en)	1997-04-21	Key pad structure
GB9725637D0 (en)	1998-02-04	Benzofurans and their therapeutic use
GB9714297D0 (en)	1997-09-10	Benzofurans and their therapeutic use
TW300468U (en)	1997-03-11	Improved structure of horizontal exerciser
TW299923U (en)	1997-03-01	Improved structure of laser pointer
ZA974375B (en)	1998-05-20	Benzofuran carboxamides and their therapeutic use.
KR970064085U (ko)	1997-12-11	펀넬 내측면부의 인너대그 도포구조
IE892759L (en)	1990-02-28	ß-CARBOLINE THEIR BENZOFURAN AND BENZTHIOPHENE ANALOGUES
TW399753U (en)	2000-07-21	Mouse pad universal-direction slippery-proof structure
TW325699U (en)	1998-01-21	Improved structure of exerciser
KR970064626U (ko)	1997-12-11	프리앰프의 실드구조
SE9600813D0 (sv)	1996-03-01	Dynamisk hantel
IT233686Y1 (it)	2000-02-03	Calotta igienico-sanitaria sotto-casco per motociclisti e simili